Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Oligodendroglioma 1Medulloblastoma 1Glioma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Specimen Handling 441Magnetic Resonance Spectroscopy 340pembrolizumab 286Biopsy 242Carboplatin 228Cisplatin 193Cyclophosphamide 177Paclitaxel 160Nivolumab 152Gemcitabine 147Bevacizumab 123Radiotherapy 120Dexamethasone 110Pemetrexed 101fludarabine 95Fluorouracil 95atezolizumab 90Radiation 90venetoclax 89Docetaxel 88Doxorubicin 86Oxaliplatin 85durvalumab 84Rituximab 83Leucovorin 81Capecitabine 75Prednisone 72Lenalidomide 69X-Rays 67Etoposide 67

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Diphtheria-Tetanus Vaccine × 30 days × Clear all
NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting
12 enrolled
CNS

Brain Neoplasms, Oligodendroglioma

NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡